CS275015B2 - Method of human insulin's analogues preparation - Google Patents
Method of human insulin's analogues preparationInfo
- Publication number
- CS275015B2 CS275015B2 CS497489A CS497489A CS275015B2 CS 275015 B2 CS275015 B2 CS 275015B2 CS 497489 A CS497489 A CS 497489A CS 497489 A CS497489 A CS 497489A CS 275015 B2 CS275015 B2 CS 275015B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- insulin
- human insulin
- thr
- analogues
- preparation
- Prior art date
Links
- PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical class C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 5
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 abstract 3
- 101000976075 Homo sapiens Insulin Proteins 0.000 abstract 2
- 102000004877 Insulin Human genes 0.000 abstract 2
- 108090001061 Insulin Proteins 0.000 abstract 2
- 229940125396 insulin Drugs 0.000 abstract 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 abstract 1
- 108010005991 Pork Regular Insulin Proteins 0.000 abstract 1
- 102000004142 Trypsin Human genes 0.000 abstract 1
- 108090000631 Trypsin Proteins 0.000 abstract 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 229910001628 calcium chloride Inorganic materials 0.000 abstract 1
- 239000001110 calcium chloride Substances 0.000 abstract 1
- 238000006555 catalytic reaction Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 239000012588 trypsin Substances 0.000 abstract 1
- 239000011701 zinc Substances 0.000 abstract 1
- 229910052725 zinc Inorganic materials 0.000 abstract 1
Landscapes
- Peptides Or Proteins (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS497489A CS275015B2 (en) | 1989-08-24 | 1989-08-24 | Method of human insulin's analogues preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS497489A CS275015B2 (en) | 1989-08-24 | 1989-08-24 | Method of human insulin's analogues preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CS497489A2 CS497489A2 (en) | 1991-03-12 |
| CS275015B2 true CS275015B2 (en) | 1991-12-17 |
Family
ID=5393680
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS497489A CS275015B2 (en) | 1989-08-24 | 1989-08-24 | Method of human insulin's analogues preparation |
Country Status (1)
| Country | Link |
|---|---|
| CS (1) | CS275015B2 (cs) |
-
1989
- 1989-08-24 CS CS497489A patent/CS275015B2/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CS497489A2 (en) | 1991-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2270599A1 (en) | Chemical modification of biomedical materials with genipin | |
| DE69635414D1 (de) | Nicht antigenische und durch peressigsäure vernetzte transplantate mit innerer kollagenschicht | |
| IS4409A (is) | Notkun á kítósan og fjölsykru í tengslum við endurmyndun á hörðum vef, ásamt ígræðlingi | |
| GR3033146T3 (en) | Modified polypeptides with increased biological activity | |
| EP0128706A3 (en) | Body implants of extracellular matrix and means and methods of making and using such implants | |
| IL86091A0 (en) | Low molecular weight heparins of regular structure,their preparation and their biological uses | |
| WO1999047176A3 (en) | Latent reactive blood compatible agents | |
| CA2006473A1 (en) | Improved anti-infective therapy | |
| AU6214190A (en) | Medical valve and method of producing the same, catheter with valve, and catheter assembly | |
| ES2161229T3 (es) | Microesferas bioterapeuticas revestidas con celulas. | |
| CA2173316A1 (en) | Local polymeric gel cellular therapy | |
| DE69426304D1 (de) | Methoden zur regulation der den magen und darm betreffenden motilitaet | |
| CA2194555A1 (en) | Implanted device containing tumor cells for the treatment of cancer | |
| PL312387A1 (en) | Proteinous microbeads of encapsulated non-dissolving gas and method of making them and their application as ultrasonic visualisation medium | |
| CA2075624A1 (en) | Ultrasound-Enhanced Delivery of Materials Through the Skin | |
| DE3586108D1 (de) | Biologisch vertraegliche implantierbare behaelter auf basis von kollagen, die die konservierung und/oder die kultivierung von zellen und/oder die kontrollierte freigabe von aktivsubstanzen ermoeglicht. | |
| IN161669B (cs) | ||
| IE960853L (en) | Vascular anticoagulant proteins | |
| LT2002063A (en) | Low-dose metformin and gliburide combinations for treating diabetes | |
| EP0336779A3 (en) | Polypeptides stabilized by covalent hydrogen bond replacements | |
| DE3686702D1 (de) | Biologisch aktive topische kollagentraegermatrix: kosmetische und pharmazeutische verwendung und verfahren zu deren herstellung. | |
| CS275015B2 (en) | Method of human insulin's analogues preparation | |
| AU1076388A (en) | High level expression in e. coli of soluble mature hil-beta and derivatives with altered biological activity | |
| RU97115180A (ru) | Способ определения токсичности действия тяжелых металлов на организм | |
| EP0136093A3 (en) | Anti-cancer factors |